Replimune Group, Inc. financial data

Symbol
REPL on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
500 Unicorn Park, Woburn, Massachusetts
State of incorporation
Delaware
Fiscal year end
March 31
Latest financial report
Q1 2024 - May 16, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.3 K % -32%
Debt-to-equity 23.2 % +63.6%
Return On Equity -48.6 % -35.7%
Return On Assets -39.5 % -25.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 61.4 M shares +6.3%
Common Stock, Shares, Outstanding 61.4 M shares +8.36%
Entity Public Float 606 M USD +24.4%
Common Stock, Value, Issued 61 K USD +7.02%
Weighted Average Number of Shares Outstanding, Basic 66.6 M shares +14.4%
Weighted Average Number of Shares Outstanding, Diluted 66.6 M shares +14.4%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 175 M USD +38.3%
General and Administrative Expense 59.8 M USD +18.3%
Operating Income (Loss) -235 M USD -32.6%
Nonoperating Income (Expense) 19.4 M USD +529%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -215 M USD -23.8%
Income Tax Expense (Benefit) 408 K USD +41.7%
Net Income (Loss) Attributable to Parent -216 M USD -23.8%
Earnings Per Share, Basic -3.24 USD/shares -8.36%
Earnings Per Share, Diluted -3.24 USD/shares -8.36%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 74.5 M USD -49.2%
Assets, Current 434 M USD -26.8%
Property, Plant and Equipment, Net 10.5 M USD +40.2%
Operating Lease, Right-of-Use Asset 4.64 M USD -11%
Assets 488 M USD -24.6%
Accounts Payable, Current 2.58 M USD -51.9%
Liabilities, Current 40.4 M USD +19.6%
Operating Lease, Liability, Noncurrent 3.77 M USD -14.1%
Other Liabilities, Noncurrent 786 K USD +66.5%
Liabilities 113 M USD +24%
Accumulated Other Comprehensive Income (Loss), Net of Tax 4.86 M USD -15.3%
Retained Earnings (Accumulated Deficit) -701 M USD -44.4%
Stockholders' Equity Attributable to Parent 375 M USD -32.6%
Liabilities and Equity 488 M USD -24.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -185 M USD -44.8%
Net Cash Provided by (Used in) Financing Activities 16.3 M USD -94.8%
Net Cash Provided by (Used in) Investing Activities 97.2 M USD
Common Stock, Shares Authorized 150 M shares 0%
Common Stock, Shares, Issued 61.4 M shares +8.36%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -72.1 M USD -277%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 76.2 M USD -48.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 3.04 M USD +186%
Deferred Tax Assets, Valuation Allowance 162 M USD +42.1%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 173 M USD +37.9%
Operating Lease, Liability 4.93 M USD -10.4%
Depreciation 700 K USD 0%
Payments to Acquire Property, Plant, and Equipment 449 K USD -58%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -217 M USD -29.3%
Lessee, Operating Lease, Liability, to be Paid 6.48 M USD -14%
Property, Plant and Equipment, Gross 20.4 M USD +38.4%
Operating Lease, Liability, Current 1.16 M USD +3.85%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.17 M USD +1.74%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.16 M USD +3.85%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.55 M USD -23.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.14 M USD -1.98%
Deferred Tax Assets, Operating Loss Carryforwards 142 M USD +51.3%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10 M shares 0%
Unrecognized Tax Benefits 8.67 M USD -1.03%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.09 M USD -3.64%
Operating Lease, Payments 1.06 M USD +4.44%
Additional Paid in Capital 1.07 B USD +3.47%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 2.66 M USD +8.5%
Share-based Payment Arrangement, Expense 8.24 M USD +17.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%